Rich-Vicks ibuprofen/pseudoephedrine patent ruled invalid by circuit court.
This article was originally published in The Tan Sheet
Executive Summary
RICH-VICKS IBUPROFEN/PSEUDOEPHEDRINE PATENT NOT VALID, a Wilmington, Del. federal appeals court ruled recently, quashing the Procter & Gamble division's hopes of having federal Judge Sue Robinson's post-trial judgment in favor of the defendants, Pharmacia & Upjohn and McNeil, overturned. The ibuprofen/pseudoephedrine combination patent was deemed not enforceable by both courts on the basis that the cough/cold product formula is "obvious," or easily derived by anyone of "ordinary skill in the art."